Table of Contents
examines the firm ’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy. Actelion is a biopharmaceutical industry player focused on the discovery, development and commercialization of synthetic, small-molecule drugs to address high unmet medical needs. The industry player has subsidiaries in more than 25 countries including the US, Canada, Brazil, Australia, ...More »
The Largest Collection of Market Research Reports
From +200,000 authoritative sources
Growth Hormone Deficiency - Pipeline Review, H2 2013 Summary Global Markets Direct's, 'Growth Hormone Deficiency - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. ...
Eiger BioPharmaceuticals, Inc. - Product Pipeline Review - 2013 Summary Global Market Direct's pharmaceuticals report, “Eiger BioPharmaceuticals, Inc. - Product Pipeline Review - 2013” provides data ...
Panacea Biotec Limited - Product Pipeline Review - 2013 Summary Global Market Direct's pharmaceuticals report, “Panacea Biotec Limited - Product Pipeline Review - 2013” provides data on the Panacea ...
... Studying a ps-targeting fully human monoclonal antibody fragment, that when joined to the imaging radio-isotope iodine- 124, holds potential to determine the effectiveness of existing and new cancer ...
... Of products from its portfolio of heat-labile enzymes. The signing of an agreement with ge healthcare adds to an expanding customer base already counting industry leaders such as new england biolabs ...
... Of the D Ib System. And error for more than years, i heard that a venture company called Hiome bioscience was building a monoclonal antibody fabrication system. Hen i had an opportunity to actually ...
Reportlinker.com © Copyright 2013. All rights reserved.